1-3 of 3
Aditi Dhir
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Arginine Methyltransferase PRMT5 Regulates Maintenance and TKI Resistance of Self-Renewing FLT3-ITD AML LSC

Harish Kumar, Mostafa Mohamed, Aditi Dhir, George M Burslem, Xinyang Zhao, Rui Lu, Erin Ahn, Ravi Bhatia
Journal: Blood
Blood (2024) 144 (Supplement 1): 1391.
https://doi.org/10.1182/blood-2024-205644
Published: 2024
Journal Articles

PRMT5 Inhibition Enhances Elimination of FLT3-ITD AML Stem Cells in Combination with TKI Treatment

Harish Kumar, Aditi Dhir, Andrew J. Paterson, Nick R Anderson, Shaowei Qiu, Xinyang Zhao, Rui Lu, Ravi Bhatia
Journal: Blood
Blood (2022) 140 (Supplement 1): 3073–3074.
https://doi.org/10.1182/blood-2022-168326
Published: 2022
Journal Articles

An Epigenetic Screen Identifies PRMT5 As a Target for Inhibition of FLT3-ITD AML Cell Growth in Combination with Tyrosine Kinase Inhibitors

Aditi Dhir, MD, Andrew J Paterson, PhD, Shaowei Qiu, MD, Amanda K Mullen, Nick R Anderson, BS, Ravi Bhatia, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2524.
https://doi.org/10.1182/blood-2019-125178
Published: 2019